Filter by:

Date
Business
4th November 2022

Business Weekly - Investments in impulse’s ‘super entrepreneurs’ top £100m

Semarion is listed as one of the alumni of Cambridge University’s successful entrepreneurship and intrapreneurship programme – impulse – which have attracted more than £100 million in funding and investments over ...
Read more
Events
16th March 2022

Semarion Highlighted in the Advanced Therapies Start-Up Report

Advanced Therapies 2022 will showcase the "100 hottest, most interesting advanced therapy medicinal products (ATMP) start-ups". Semarion is excited to be part that! While we our SemaCyte® technology is not a therapeutic...
Read more
Business
4th March 2022

Semarion CEO to be listed as #21toWatch Top21.2022

Our CEO, Jeroen Verheyen, was listed as #21toWatch Top21.2022 by Cofinitive, alongside other great people, companies, and 'things'....
Read more
Technology
28th February 2022

Biopharma Reporter - Startup looking to create paradigm shift in cell screening

While assays with suspension cells have benefitted from lots of innovative solutions, such as those using cytometry or microfluids, there has been a lack of innovation for adherent cell assays. The anchorage dependance l...
Read more
Business
22nd February 2022

Semarion raises £2.14m seed funding to commercialise cell assaying platform

Funding will support recruitment, commercial partnerships, and further development of Semarion’s SemaCyte cell assaying platform, which turns adherent cells into liquid reagents to enable novel drug screening methodolo...
Read more
Events
15th November 2021

Semarion to present as one of the Rising Biotech Stars at Genesis 2021

We are pleased to announce that we will be presenting at the Genesis 2021 conference organised by One Nucleus. Our CEO, Jeroen Verheyen, will summarise what Semarion is building at the Rising Biotech Stars. This content ...
Read more
Partnering
27th July 2021

University Enterprise Zone - Semarion as case study for Connect Health Tech

As a spin-out company from the University of Cambridge, Semarion and its co-founders, Jeroen & Tarun, have gained support from a variety of networks, such as the NanoDTC, the Cambridge CRUK Early Detection Programme, the...
Read more
Events
10th September 2020

Semarion receives runner up prize for the "Pitch and Partner Panel" at the Advanced Therapies Congress & Expo 2020

Advanced Therapies is Europe’s most important advanced therapies conference and exhibition. Semarion is excited to have received the runner up prize for the startup pitch it delivered at the "Pitch and Partner Panel" s...
Read more
Events
7th July 2020

Semarion presents at On Helix 2020

Semarion is excited about attending On Helix 2020. Connect with our CEO Jeroen Verheyen or CTO Tarun Vemulkar if you are there. Jeroen will and speaking during the "Rising Biotech Stars" session (13 July 16.30 BST) about...
Read more
Events
1st July 2020

Semarion to speak at the "Life Science Entrepreneurs + Accelerators Digital Meetup"

Are you an entrepreneur or a potential entrepreneur thinking about starting a company? Join accelerators, founders and ecosystem builders for this digital meetup for entrepreneurs to celebrate our startup ecosystem! Sema...
Read more
Events
23rd June 2020

Semarion Pitches at the Milner Therapeutics Symposium 2020

Semarion will join the Milner Therapeutics Symposium 2020 on June 26th to speak about revolutionizing cell-based assays using SemaCyte microcarriers. We will be pitching alongside other Cambridge-based biotech startups. ...
Read more
Business
22nd June 2020

Semarion to join the Start Codon programme and receive £250k pre-seed investment

Start Codon, a new model of life science and healthcare business accelerator, today proudly debuts its first cohort of start-up companies. Start Codon aims to minimise risk and translate early stage research into success...
Read more